RT @jacquoisuk: A recent study flagged by a colleague who is interested in the use of research based treatments for VMS in #menopause. We n…
A recent study flagged by a colleague who is interested in the use of research based treatments for VMS in #menopause. We need more to inform decisions @Boost_NENC @NENCproviders @BrMenopauseSoc https://t.co/Ve54dTwGD8
SR: Paroxetine is the only FDA approved non-hormonal treatment for hot flashes; But 68% of the mean treatment response for hot flash severity is accounted for by a placebo response, resulting in a maximum true drug effect of 32% (79% and 21% for frequency)
New Research: Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis: Introduction Vasomotor symptoms, or hot flashes, are among the most common complaints for menopausal and postmenopausal… #Psychiatry http